Minocycline as adjunct therapy for a male patient with deficit schizophrenia
Xiaohua Chen,1,* Zhenzhen Xiong,2,* Zhixiong Li,3 Yali Yang,4 Zhanying Zheng,5 Yonghong Li,6 Yan Xie,6 Zhe Li7,8 1Department of Central Transportation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; 2School of Nursing, Chengdu Medical College, Chengdu, Sichuan 61008...
Guardado en:
Autores principales: | Chen X, Xiong Z, Li Z, Yang Y, Zheng Z, Li Y, Xie Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7e8b878cb4a405c987b57fb7dfac5d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013) -
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
por: Husain MI, et al.
Publicado: (2016) -
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
por: Beyazyüz M, et al.
Publicado: (2016) -
Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function
por: Pan LH, et al.
Publicado: (2020) -
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo K, et al.
Publicado: (2019)